Digital Edition: MedTech Strategist September 2022, vol. 9 #8

article image

Lisa Earnhardt reflects on Abbott's rise to the top tier of medtech multinationals; L.E.K. Consulting breaks down the current supply chain crisis and addresses strategies for navigating through it; after years of stagnation, new technologies are helping drive growth in the foot and ankle surgery market; by making medtech innovation systemic and reproducible, Israel's Sheba Medical hopes to stave off the looming healthcare financial crisis. Plus profiles of Foldax and Phiex Technologies.


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: